缬沙坦-话题@MedSci

#缬沙坦#

58篇内容 | 2803人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1367688, encodeId=435d136e6885e, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Eur Heart J：沙库巴曲缬沙坦可降低HFpEF患者的明显顽固性高血压, objectType=article, longId=215968, objectId=868121596818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868121596818, replyNumber=0, likeNumber=77, createdTime=2021-08-20, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868121596818, moduleTitle=Eur Heart J：沙库巴曲缬沙坦可降低HFpEF患者的明显顽固性高血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=868121596818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367687, encodeId=e9fc136e687ca, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=JAHA：沙比特利/缬沙坦对射血分数正常的心衰患者血脂的影响, objectType=article, longId=211493, objectId=971f211493b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=971f211493b3, replyNumber=0, likeNumber=68, createdTime=2021-05-20, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=971f211493b3, moduleTitle=JAHA：沙比特利/缬沙坦对射血分数正常的心衰患者血脂的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=971f211493b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367686, encodeId=1184136e6861c, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Eur Heart J Cardiovasc Pharmacother：慢性心力衰竭患者的肾脏保护：关注沙库巴曲/缬沙坦, objectType=article, longId=209879, objectId=1f592098e993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f592098e993, replyNumber=0, likeNumber=106, createdTime=2021-04-14, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f592098e993, moduleTitle=Eur Heart J Cardiovasc Pharmacother：慢性心力衰竭患者的肾脏保护：关注沙库巴曲/缬沙坦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f592098e993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367685, encodeId=d6f7136e6856d, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=J Am Coll Cardiol：沙库巴曲缬沙坦治疗射血分数保留型患者的更佳收缩压应控制在多少, objectType=article, longId=207799, objectId=582b20e79945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=582b20e79945, replyNumber=0, likeNumber=119, createdTime=2021-03-03, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=582b20e79945, moduleTitle=J Am Coll Cardiol：沙库巴曲缬沙坦治疗射血分数保留型患者的更佳收缩压应控制在多少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=582b20e79945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367684, encodeId=6d49136e6842e, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=J Coll Physicians Surg Pak：缬沙坦单用或与硫辛酸合用对早期糖尿病肾病患者炎症细胞因子和肾功能的疗效观察, objectType=article, longId=195985, objectId=570a195985e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=570a195985e5, replyNumber=0, likeNumber=85, createdTime=2020-06-18, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=570a195985e5, moduleTitle=J Coll Physicians Surg Pak：缬沙坦单用或与硫辛酸合用对早期糖尿病肾病患者炎症细胞因子和肾功能的疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=570a195985e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367683, encodeId=52c7136e68362, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Diabetes Obes Metab：缬沙坦，贝那普利及其组合对2型糖尿病明显肾病的作用, objectType=article, longId=195983, objectId=007c19598331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007c19598331, replyNumber=0, likeNumber=68, createdTime=2020-06-18, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007c19598331, moduleTitle=Diabetes Obes Metab：缬沙坦，贝那普利及其组合对2型糖尿病明显肾病的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=007c19598331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367682, encodeId=5a48136e682d0, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Circulation：LVEF影响沙卡布曲-缬沙坦的治疗心衰的效果, objectType=article, longId=187621, objectId=0fe218e62118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fe218e62118, replyNumber=0, likeNumber=53, createdTime=2020-02-08, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fe218e62118, moduleTitle=Circulation：LVEF影响沙卡布曲-缬沙坦的治疗心衰的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fe218e62118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367681, encodeId=d2c5136e68167, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Circulation：沙卡布曲-缬沙坦对比缬沙坦治疗保留射血分数心衰的性别差异, objectType=article, longId=187616, objectId=2c9518e616ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c9518e616ea, replyNumber=0, likeNumber=53, createdTime=2020-02-08, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c9518e616ea, moduleTitle=Circulation：沙卡布曲-缬沙坦对比缬沙坦治疗保留射血分数心衰的性别差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c9518e616ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367680, encodeId=7b92136e68052, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=NEJM：沙库巴曲缬沙坦对低射血分数为45%以上心力衰竭患者的影响, objectType=article, longId=181910, objectId=261f181910b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261f181910b2, replyNumber=0, likeNumber=63, createdTime=2019-10-26, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261f181910b2, moduleTitle=NEJM：沙库巴曲缬沙坦对低射血分数为45%以上心力衰竭患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=261f181910b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367679, encodeId=cf4a136e67910, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=缬沙坦价格飙升创10年新高！, objectType=article, longId=166687, objectId=051c16668e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=051c16668e52, replyNumber=0, likeNumber=71, createdTime=2019-05-25, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=051c16668e52, moduleTitle=缬沙坦价格飙升创10年新高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=051c16668e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367678, encodeId=daea136e67803, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=缬沙坦全球召回事件已波及日本全球或迎来降压药短缺, objectType=article, longId=160836, objectId=e90c160836b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e90c160836b3, replyNumber=0, likeNumber=83, createdTime=2019-02-24, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e90c160836b3, moduleTitle=缬沙坦全球召回事件已波及日本全球或迎来降压药短缺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e90c160836b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367677, encodeId=e8c0136e677f7, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=NEJM：急性失代偿性心衰：沙卡布曲-缬沙坦vs依那普利, objectType=article, longId=156513, objectId=29ce156513a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29ce156513a1, replyNumber=0, likeNumber=47, createdTime=2018-12-25, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29ce156513a1, moduleTitle=NEJM：急性失代偿性心衰：沙卡布曲-缬沙坦vs依那普利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29ce156513a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367676, encodeId=1a37136e67697, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Circulation：采用沙普替利/缬沙坦治疗慢性肾病，额外具有降血压和心肌标志物的作用, objectType=article, longId=150938, objectId=bb0a150938cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb0a150938cb, replyNumber=0, likeNumber=82, createdTime=2018-10-14, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb0a150938cb, moduleTitle=Circulation：采用沙普替利/缬沙坦治疗慢性肾病，额外具有降血压和心肌标志物的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb0a150938cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367675, encodeId=88d3136e675c4, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=缬沙坦事件，FDA认错了！, objectType=article, longId=150854, objectId=689315085486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=689315085486, replyNumber=0, likeNumber=65, createdTime=2018-10-13, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=689315085486, moduleTitle=缬沙坦事件，FDA认错了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=689315085486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367674, encodeId=919c136e6746a, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=BMJ权威研究：被NDMA污染的缬沙坦药物短期内不会增加患者致癌风险, objectType=article, longId=149190, objectId=f21f1491906b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f21f1491906b, replyNumber=0, likeNumber=66, createdTime=2018-09-22, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f21f1491906b, moduleTitle=BMJ权威研究：被NDMA污染的缬沙坦药物短期内不会增加患者致癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f21f1491906b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367673, encodeId=d4cc136e6737f, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=BMJ：N-二甲基亚硝胺(NDMA)污染的缬沙坦致癌风险评估, objectType=article, longId=148857, objectId=182814885e1d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=182814885e1d, replyNumber=0, likeNumber=88, createdTime=2018-09-16, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=182814885e1d, moduleTitle=BMJ：N-二甲基亚硝胺(NDMA)污染的缬沙坦致癌风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=182814885e1d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367672, encodeId=fcc0136e67260, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=FDA宣布缬沙坦全新调查结果：扩大排查范围！, objectType=article, longId=148029, objectId=31b4148029c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31b4148029c7, replyNumber=0, likeNumber=73, createdTime=2018-09-03, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31b4148029c7, moduleTitle=FDA宣布缬沙坦全新调查结果：扩大排查范围！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31b4148029c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367671, encodeId=7565136e671ff, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=在缬沙坦召回事件1年多前，FDA已经发现了华海药业的生产问题, objectType=article, longId=146507, objectId=d1fc14650ed6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1fc14650ed6, replyNumber=0, likeNumber=81, createdTime=2018-08-14, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1fc14650ed6, moduleTitle=在缬沙坦召回事件1年多前，FDA已经发现了华海药业的生产问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1fc14650ed6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367670, encodeId=2cba136e670cb, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, objectType=article, longId=141968, objectId=8ab4141968fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab4141968fd, replyNumber=0, likeNumber=87, createdTime=2018-07-01, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab4141968fd, moduleTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab4141968fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367669, encodeId=2c4c136e66980, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Heart：缬沙坦治疗慢性心衰伴射血分数降低具有成本效益, objectType=article, longId=139945, objectId=6f0f13994528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f0f13994528, replyNumber=0, likeNumber=70, createdTime=2018-06-06, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f0f13994528, moduleTitle=Heart：缬沙坦治疗慢性心衰伴射血分数降低具有成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f0f13994528)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

缬沙坦

2020-05-29

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Eur Heart J：沙库巴曲缬沙坦可降低HFpEF患者的明显顽固性高血压

2021-08-20

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

JAHA：沙比特利/缬沙坦对射血分数正常的心衰患者血脂的影响

2021-05-20

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Eur Heart J Cardiovasc Pharmacother：慢性心力衰竭患者的肾脏保护：关注沙库巴曲/缬沙坦

2021-04-14

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

J Am Coll Cardiol：沙库巴曲缬沙坦治疗射血分数保留型患者的更佳收缩压应控制在多少

2021-03-03

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

J Coll Physicians Surg Pak：缬沙坦单用或与硫辛酸合用对早期糖尿病肾病患者炎症细胞因子和肾功能的疗效观察

2020-06-18

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Diabetes Obes Metab：缬沙坦，贝那普利及其组合对2型糖尿病明显肾病的作用

2020-06-18

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Circulation：LVEF影响沙卡布曲-缬沙坦的治疗心衰的效果

2020-02-08

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Circulation：沙卡布曲-缬沙坦对比缬沙坦治疗保留射血分数心衰的性别差异

2020-02-08

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

NEJM：沙库巴曲缬沙坦对低射血分数为45%以上心力衰竭患者的影响

2019-10-26

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

缬沙坦价格飙升创10年新高！

2019-05-25

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

缬沙坦全球召回事件已波及日本全球或迎来降压药短缺

2019-02-24

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

NEJM：急性失代偿性心衰：沙卡布曲-缬沙坦vs依那普利

2018-12-25

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Circulation：采用沙普替利/缬沙坦治疗慢性肾病，额外具有降血压和心肌标志物的作用

2018-10-14

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

缬沙坦事件，FDA认错了！

2018-10-13

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

BMJ权威研究：被NDMA污染的缬沙坦药物短期内不会增加患者致癌风险

2018-09-22

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

BMJ：N-二甲基亚硝胺(NDMA)污染的缬沙坦致癌风险评估

2018-09-16

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

FDA宣布缬沙坦全新调查结果：扩大排查范围！

2018-09-03

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

在缬沙坦召回事件1年多前，FDA已经发现了华海药业的生产问题

2018-08-14

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？

2018-07-01

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Heart：缬沙坦治疗慢性心衰伴射血分数降低具有成本效益

2018-06-06

科室
- - 订阅+
  - 更多科室
工具
服务